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Abstract
Background: Iron deficiency, anemia and hookworm disease are important public health problems for women of
reproductive age living in developing countries and affect the health of newborns and infants. Iron supplementation and
deworming treatment are effective in addressing these problems in both pregnant and non-pregnant women. Daily iron
supplementation and deworming after the first trimester is recommended for pregnant women although these programs
usually do not operate efficiently or effectively. Weekly iron-folic acid supplementation and regular deworming for non-
pregnant women may be a viable approach for improving iron status and preventing anemia during the reproductive
years. Addressing these diseases at a population level before women become pregnant could significantly improve
women's health before and during pregnancy, as well as their infants' growth and development.
Methods and Results: This paper describes the major processes undertaken in a demonstration intervention of
preventive weekly iron-folic acid supplementation with regular deworming for all 52,000 women aged 15–45 years in two
districts of Yen Bai province, in northern Viet Nam. The intervention strategy included extensive consultation with
community leaders and village, commune, district and provincial health staff, and training for village health workers.
Distribution of the drugs was integrated with the existing health service infrastructure and the village health workers
were the direct point of contact with women. Iron-folic acid tablets and deworming treatment were provided free of
charge from May 2006. An independent Vietnamese NGO was commissioned to evaluate compliance and identify
potential problems. The program resulted in effective distribution of iron-folic acid tablets and deworming treatment to
all villages in the target districts, with full or partial compliance of 85%.
Conclusion: Training for health staff, the strong commitment of all partners and the use of appropriate educational
materials led to broad support for weekly iron-folic acid supplementation and high participation in the regular deworming
days. In March 2008 the program was expanded to all districts in the province, a target population of approximately
250,000 WRA, and management was handed over to provincial authorities.
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Iron deficiency and anemia are important public health
problems for women of reproductive age (WRA) living in
developing countries. Iron deficiency has been estimated
to cause 30–70% of all maternal anemia [1]. Hookworm
infection is a significant predictor of poor iron status and
iron deficiency anemia in pregnant and lactating women,
and is also a disease of public health importance globally.
Iron deficiency anemia is an important factor in suscepti-
bility to infectious disease [2], decreased work capacity
[3,4], and maternal death [5]. Maternal anemia may have
an effect on preterm birth [6] and has been shown to be a
significant predictor of low birth weight [7-9] and iron
deficiency in infants, which has negative effects on child
development [10,11].
Interventions to control anemia and hookworm infections
The main interventions that have been implemented to
address iron deficiency anemia include iron supplementa-
tion, iron fortification of foods and nutrition education
programs [1]. The World Health Organization (WHO)
recommends routine daily iron supplementation during
pregnancy [12]. However, few countries have reported
improvement in anemia rates at a national level and, gen-
erally, the effects of large scale daily iron supplementation
in pregnancy have been disappointing due to poor com-
pliance [13-15], cost [16], side effects [17,18], and lack of
education about the importance of iron in pregnancy
[19].
Recent evidence suggests that weekly iron-folic acid sup-
plementation (WIFS) is as effective as daily supplementa-
tion for reducing the burden of iron deficiency anemia in
non-pregnant WRA [20-24], and WHO recently released a
position statement recommending WIFS for WRA in areas
where the prevalence of anemia is above 20% [25]. How-
ever, there are few studies reporting the operational con-
siderations in large-scale community-based WIFS
programs [26,27].
This paper will describe the lessons learned from the
implementation of a preventive WIFS and deworming
program for WRA living in Yen Bai province, northern Viet
Nam, and summarizes the experiences and factors that
should be considered in future programs. The main aims
of the program were to measure the prevalence of anemia
and hookworm infection in WRA; implement a demon-
stration WIFS/deworming intervention for WRA in order
to reduce the prevalence of iron deficiency anemia and
hookworm infection in this group; and to provide evi-
dence of the feasibility, effectiveness, compliance, sustain-
ability and cost of the program.
Methods and results
Project design
1. Project site
Yen Bai province was chosen as the project site because it
was identified as a poor rural province that was expected
to have high rates of anemia and hookworm infection.
The province of Yen Bai consists of nine administrative
towns and districts. Governance in the province is by pro-
vincial civil committees (People's Committee, Commu-
nist Party Committee) and service departments (e.g.
Department of Health Services etc), through their district
and commune counterparts, to the village and hamlet
level.
2. Situation analysis and formative research
Project staff visited Yen Bai province in April 2005 to
undertake a situation analysis and collect background
information from key informants that could be used to
design an initial survey to measure the prevalence of ane-
mia, iron deficiency and hookworm infection in WRA
(defined by the Yen Bai Health Service as women aged
16–45 years). The Yen Bai Centre for Malariology, Parasi-
tology and Entomology (CMPE) was identified as an
appropriate provincial project partner.
Meetings were convened with health officials, clinicians,
teachers, members of community organizations and the
general community to discuss a WIFS/deworming inter-
vention and address logistic considerations, such as the
operational and human capacity to implement the inter-
vention. Other information gathered included the demo-
graphic characteristics of the population, presence of
existing infrastructure, details of other local and interna-
tional groups working in Yen Bai, and the geography and
transport routes of the province. National policies regard-
ing prevention and control of intestinal parasite infections
and prevention and control of iron deficiency and/or ane-
mia were also reviewed.
In November 2005 a baseline survey of anemia and hook-
worm prevalence was undertaken in Tran Yen and Yen
Binh districts [28]. Demographic and socio-economic
data from this survey is presented in Table 1. The preva-
lence of anemia (Hb<120 g/L) was 37.5% (131/349) and
the prevalence of iron deficiency (ferritin <15 μ g/L) was
23.1% (81/349). Hookworm infection was present in
78.2% (261/334) of women. On the basis of these results,
it was decided to proceed with a WIFS/deworming inter-
vention that targeted approximately 52,000 WRA in two
districts, and if successful to scale up to a province-wide
program. For this and all other surveys informed consent
was documented prior to enrolment.Page 2 of 10
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vention as they were easy to reach, and had a representa-
tive population of Kinh and ethnic minority groups. It was
decided that the supplements would have to be actively
supplied and free of charge in order to be equitable for
poor families, for ease of administration and to aid com-
pliance. Provincial and district health staff recommended
that village health workers (VHWs) play a key role in
delivery of deworming and iron supplements to WRA
because they had direct access to women in their commu-
nities and could work with the Women's Union to mobi-
lize the target group and support project and health
promotion activities.
3. Project administration and funding
The University of Melbourne (UoM) and the Walter and
Eliza Hall Institute of Medical Research (WEHI) were the
international partners; the Viet Nam National Institute for
Mariology, Parasitology and Entomology (NIMPE) the
national implementing agency; the Yen Bai CMPE the
provincial implementing agency; and WHO Hanoi pro-
vided technical advice. During the late planning stages it
became apparent that implementation and monitoring
would benefit from a Viet Nam-based project manager.
WHO Western Pacific Regional Office gave advice regard-
ing the WIFS component of the program. Funding was
obtained from Atlantic Philanthropies (USA) Inc.
Implementation of the program
The project was implemented in stages as shown in Figure
1 after further meetings with the provincial People's Com-
mittee and health services and district and commune
health staff to discuss the purpose and methodology of
the intervention.
1. Advocacy and IEC materials
Promotional materials were developed in conjunction
with commune health staff and VHW and included post-
ers for health staff (4 copies for every village and com-
mune) and a pictorial handout with timetable for all WRA
(Figure 2). These were field tested at selected sites prior to
implementation.
The main messages that were communicated to the
women on the handout were:
"Healthy Women – Healthy Families"
 All women aged 16–45 should take deworming and
iron to ensure good health
 Deworming and iron help women to feel and work
better
 Take deworming and iron to provide a healthy
happy environment for children
 If you think you are pregnant go to commune health
station
 If you feel sick go to the commune health station
 Keep all tablets away from children
In addition, banners were produced at all commune
health stations for the launch of the intervention. Provin-
cial television coverage including interviews with major
partners was also organised.
2. Training and incentives for health staff
Before the intervention was implemented, a one week
Training of Trainers session was conducted by experienced
NIMPE trainers for four CMPE staff. These staff then con-
ducted two day training sessions for four staff of each dis-
trict Centre for Preventive Medicine, two nurses from each
commune health station and all VHW in the two districts,
a total of 680 health personnel. The training focused on
Table 1: Demographic and socioeconomic data for WRA in study 
area, November 2005, Yen Bai Province, Viet Nam. (N = 382*)
Variable N (%)
Mean Age
(95% CI)
31.73
(30.93–32.53)
Marital status Married 320 (85%)
Not married 54 (14%)
Divorced/Widow 3 (<1%)
Number of children Median
(range)
2
(0–5)
Ethnicity Kinh 252 (66%)
Tay 46 (12%)
Cao Lan 29 (8%)
Dao 50 (13%)
Other 3 (<1%)
Education level Illiterate 27 (7%)
To Grade 5 57 (15%)
Grade 6–9 210 (56%)
Grade 10–12 70 (19%)
Higher 10 (3%)
Current pregnancy status Pregnant 6 (2%)
Not pregnant 370 (98%)
Frequency of wearing shoes Never 44 (12%)
Occasionally 184 (50%)
Always 142 (38%)
* Failure to sum to 382 indicates the woman's uncertainty or no 
response.Page 3 of 10
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mia and hookworm infection: use of the IEC materials;
effective IEC dissemination skills: distribution strategy:
reporting requirements and responsibilities: monitoring,
reporting and responding to adverse events: and monthly
follow up of women. All staff (including VHW, commune
and district staff) involved in the project received a small
monthly stipend during the implementation period.
3. Distribution strategy
A bulk supply of iron-folic acid tablets was procured from
UNICEF Copenhagen. NIMPE was responsible for ensur-
ing timely transfer to the province. In the province the tab-
lets were stored centrally at the CMPE. Population
estimates were taken from the Yen Bai Statistics Hand-
book, 2004 [29] and the number of women targeted was
52,000.
The transfer of tablets to each district occurred during the
approximately monthly visits by the districts' Centres of
Preventive Medicine personnel to the CMPE for supplies
and administrative requirements, to the commune during
the monthly meeting attended by commune health sta-
tion staff held at the Centre of Preventive Medicine in all
districts, and by commune staff to VHWs. VHWs then dis-
tributed the tablets on a monthly basis to the WRA in their
village.
Reporting at each stage included number of tablets
received, number disbursed, number of women accessing
the service and, from the commune, adverse events.
4. Intervention
The implementation period for the demonstration project
was from May 2006 to April 2007. No other interventions
Design and evaluation of a preventive WIFS and deworming programFigure 1
Design and evaluation of a preventive WIFS and deworming program. *WRA = Women of Reproductive Age 
defined as 16 – 45 years. IEC = Information, Education and Communication. WIFS = Weekly Iron-Folic acid Supplementation.
Total WRA* population in Tran 
Yen and Yen Binh districts. 
Approximate n = 52 000 Intervention Evaluation 
Baseline survey
November 2005
n=382 
Follow-up Survey 2 (12 months)
April 2007 
n=577 
Follow-up Survey 1 (3 months)
August 2006 
n=582 
February - April 2005 
Development and distribution of 
IEC* materials 
Training of health personnel 
from province, districts, 
communes and villages 
March 2008 
Expansion to all WRA in Yen Bai province 
(estimated 250 000 WRA) 
 May 2006  to  April 2007  
54 weekly doses of iron-folic 
acid  
(Distributed 4 per woman every 
month)  
and 
4 doses of albendazole 400 mg 
(Distributed May 06, September 
06, January 07 and May 07, 
black arrows) 
WIFS* continued in 2 pilot 
districts May 2007 – March 
2008 prior to provincial 
expansion 
Compliance survey
July 2006  
n=253  
Compliance survey
September 2007  
n=276
Mid term review December 2006 Page 4 of 10
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2005, when the baseline survey was conducted, and May
2006 when the WIFS/deworming intervention com-
menced. WIFS/deworming was continued in the two dis-
tricts from May 2007 to March 2008 when a province-
wide expansion was implemented.
Iron tablets
Free monthly supply of ferrous sulphate/folic acid tablets
(200 mg, equal to 60 mg elemental iron/0.4 mg folic acid,
UNICEF, Copenhagen) to be taken weekly was given
directly to WRA by VHW. The tablets were coated, brown/
red in colour and were supplied in double-lidded tamper
proof bottles to the women (i.e. 4 tablets per bottle per
month). The women were strongly instructed to keep the
bottles out of reach of children and the bottles were also
labeled with this information. To aid compliance, women
were encouraged by the VHWs to take the iron-folic acid
tablet on the same day each week and were given instruc-
tions about swallowing the tablets with water, not taking
them on an empty stomach, and also avoiding tea/coffee
at the time of taking the tablets.
The Viet Nam Ministry of Health guidelines recommend
pregnant women take one iron-folic acid tablet (120 mg/
0.4 mg) daily, distributed through commune health sta-
tions. In the communes where this program was opera-
tional, women who became pregnant were advised to
access this service instead of taking the WIFS; however it
was not universally available. In areas where it was not
available, pregnant women were provided with an addi-
tional weekly ferrous sulphate tablet (60 mg elemental
iron, UNICEF, Copenhagen), to be taken from the second
trimester until three months post-partum.
Deworming
Albendazole (400 mg, UNICEF, Copenhagen) was
administered to non-pregnant women as observed treat-
ment on locally designated days either at the commune
health station or supervised in the village by a commune
First promotional handout for women, April/May 2006igure 2
First promotional handout for women, April/May 2006.Page 5 of 10
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women whether they were pregnant and the timing of
their last menstrual period. In this way, we were able to
follow government guidelines, which avoid giving
deworming treatment to pregnant women. The tablets
were supplied in tins of 100. Tablets were non-coated and
white in colour. Women were observed for 30 minutes at
the health station after administration of the tablets to
ensure vomiting did not prevent consumption of the tab-
let.
5. Monitoring and Evaluation
(i) Compliance monitoring
The Research and Training Centre for Community Devel-
opment (RTCCD) was commissioned to evaluate compli-
ance in July 2006, 3 months after commencement of the
intervention, and again in September 2007. A stratified
multi-stage cluster sampling design was used. Primary
sampling units (villages) were chosen using a 'probability
proportional to size' random sampling method. Second-
ary sampling units (individual women) were selected ran-
domly from each village. In the first survey 253 women
were interviewed using a structured questionnaire, and in
the second survey 276 women were interviewed. The sur-
veys also reported that there were no interruptions in sup-
ply of tablets over the period of the intervention.
(ii) Anemia, iron deficiency and hookworm prevalence surveys
The same stratified multi-stage cluster sampling design for
choosing women for the baseline survey was used for the
three (August 2006, n = 338) and 12 (April 2007, n =
364)-month follow-up surveys. Although we were mainly
interested in the population effect of the intervention,
women who took part in the baseline survey were also
invited to participate in follow-up surveys in August 2006
(n = 244) and April 2007 (n = 213) to allow monitoring
of individual responses, and to compare the outcome var-
iables (Hb, ferritin, and parasite infection) between sub-
jects included in the baseline survey with those who were
not, to allow for the possibility that inclusion in the base-
line survey might affect compliance with the intervention
and hence response to treatment. All surveys were con-
ducted by the same teams and included trained phleboto-
mists, stool preparation and analysis technicians, a
demographic recorder and a supervisor. Sample collection
and laboratory analysis has been previously reported [28]
and was the same in each of the surveys.
(iii) Survey results
The results of monitoring and evaluation surveys will be
published elsewhere. In summary, independent monitor-
ing using structured questionnaires identified that full
compliance with iron-folic acid tablets (taking all tablets
as scheduled) was 69% (191/276) and partial compliance
(taking some but not all tablets) a further 16% (43/276)
at the end of demonstration project. The laboratory-based
survey after twelve months identified that anemia preva-
lence had fallen from 37.5% to 19.5% (111/569) and
hookworm prevalence from 78.2% to 25.1% (117/467).
6. Feedback and project responses
Monthly trips to district centres, communes and villages
were undertaken by the project team to identify problems
and areas in need of more support. Formal and informal
meetings were held with provincial Women's Union lead-
ers, commune Communist Party heads and village leaders
and presentations were made to outline the impact of the
project and to ensure continued support.
One of the recommendations from the first compliance
survey in July 2006 was that stronger project promotion
was required in mountainous communes with high pro-
portions of ethnic minority groups. In response, a calen-
dar was produced for all women in the project districts.
This displayed photos of healthy women from various
ethnic minority groups with healthy babies and photos of
healthy foods. In addition an iron-folic acid tablet was
depicted on every Sunday as a memory aid.
VHWs requested a more comprehensive collection of edu-
cational materials to use in IEC activities. The materials
developed included a set of nine posters, five for hook-
worm and four for anemia, with photos and simple mes-
sages on one side and questions and answers for
discussion on the reverse side. The messages placed more
emphasis on the causes and health consequences of ane-
mia and hookworm infection for both women and new-
borns and the benefits to both of treating and controlling
these diseases. Further information was made available
for broadcasting over the village loudspeaker system.
Considerable confusion about the extra iron tablet for
pregnant women was also identified. Women were unsure
about whether to access both project and government
iron or only one source. In response, the message was
reinforced that women should take the government daily
supplement where available, and if not available, they
should access the extra weekly tablet through the WIFS
program.
The use of plastic bottles was also a problem for both
VHWs and WRA. For the VHW, receiving bulk tablets and
having to distribute them was inconvenient and ineffi-
cient. Women found that the bottle was easy to forget or
misplace and an unacceptable number of tablets were
spoiled. To overcome these issues subsequent iron-folic
acid tablets for the expansion were sourced from a Viet-
namese pharmaceutical manufacturer (Naphaco, Nam
Dinh) and packaged in purposely designed modified blis-
ter packs. These packs contained six tear-off strips each
with five tablets.Page 6 of 10
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A one day workshop was organized by the project partners
in conjunction with the Yen Bai People's Committee and
Yen Bai Health Services. The meeting was held in Yen Bai
city in December 2006. Participants included representa-
tives from district health authorities and People's Com-
mittees, Women's Union, provincial and district hospitals
as well as members of the project team from NIMPE,
RTCCD, UOM and WHO.
8. Ethics
The project was approved by the Human Research Ethics
Committee of the National Institute of Malariology, Para-
sitology and Entomology (Hanoi, Vietnam), the Walter
and Eliza Hall Institute of Medical Research (Melbourne,
Australia) and Melbourne Health (Melbourne, Australia).
Discussion
The most important underlying concept in the develop-
ment of the WIFS/deworming treatment project was that
it would eventually become sustainable and have broad
community support. Therefore, the design included wide-
ranging, open discussions and involvement of all partners
from international to local level. As a result everyone
understood the goals, benefits and underlying principles
of the project, and had the flexibility needed to adapt to
particular local conditions in order to achieve these goals.
Table 2 summarizes the main lessons learned. An impor-
tant consideration was that VHWs received training that
included health information and IEC skill development,
as they were the critical point of contact with WRA. A sec-
ond consideration was that the IEC program needed to
provide information about anemia and soil-transmitted
helminths (STH) and their consequences, treatment and
control in an easily understood format.
In Viet Nam the health system generally enjoys a strong
vertical structure from the provincial level down to the vil-
lage. Hence, successfully integrating the introduction of
iron-folic acid tablets and the administrative monitoring
process was a matter of making small modifications to the
existing system. This process may require more attention
in countries where the health service structure is weaker.
In Viet Nam the critical factors for the successful integra-
tion of this program were, i) the active support of the rel-
evant political and health authorities, ii) a clear
understanding by all parties of the health issues and how
the program addressed those issues, iii) a simple distribu-
tion process and iv) active provision of WIFS/deworming
to WRA.
Monitoring and evaluation of the project were conducted
at two levels. The impact on women's iron status and
worm burden was assessed through follow-up laboratory
surveys conducted as part of the project. Independent
monitoring by RTCCD was utilized to assess compliance,
acceptability, promotional effectiveness and general day
to day management issues. The three month compliance
survey was useful because it identified intrinsic problems
that needed to be addressed for the long term success of
the program. We used the sixteen month (September
2007) survey to assess compliance as well as the likely
impact of handing over the program to the province, and
to identify areas that would need assistance prior to the
external collaborators withdrawal from regular manage-
ment. One of the findings of this survey was that women
liked the colourful calendars but they did not have a great
effect on compliance. The community education meetings
were a greater factor in maintaining high compliance.
Repackaging of tablets in a modified blister pack was also
greatly appreciated by both VHWs and the women.
A guiding principle of the project was that the supple-
ments be provided free of charge to all WRA. This ensured
that there was equitable distribution to poorer women
especially ethnic minority groups. It also avoided a com-
plicated system of cost recovery and helped achieve high
compliance levels.
In our project, women were asked if they were pregnant at
each deworming event and if so advised not to take the
treatment in accordance with Vietnamese guidelines.
WHO evaluated publicly available and confidential
reports of more than 6000 women that had inadvertently
taken mebendazole or albendazole during pregnancy and
concluded that the use of anthelminthic drugs during
pregnancy does not increase the risk of harm to the foetus.
They recommend that single dose oral anthelminthic can
be given to pregnant and lactating women but should be
avoided in the first trimester [30]. Reassuringly, studies in
Sri Lanka [31], Sierra Leone [32] and Nepal [33] have con-
sistently found that anthelminthic treatment during preg-
nancy significantly improved iron status and increased
newborn body weight. Despite this clarification from
WHO, several countries (including Viet Nam) are still
reluctant to administer anthelminthic therapy at any stage
during pregnancy. In order to reduce the potential for
inadvertent treatment of women in the first trimester of
pregnancy participating in mass deworming programs the
questions 'Are you pregnant?' and 'When was your last
menstrual period?' can be used to screen for pregnancy
and should be asked prior to administration [30,34].
However, studies on the effectiveness of these questions as
screening tools have not been reported. Further research
on this issue would be of great benefit to future programs.
The other issue for program managers is to consider fol-
low-up procedures for women who have deworming
treatment withheld during pregnancy, so that these
women have access to treatment at the earliest possible
time.Page 7 of 10
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throughout Yen Bai province. The ownership of the
project and training of VHWs has been transferred to the
provincial and district authorities and their communities.
Delivery of Vietnamese-produced iron-folic acid supple-
ments to Yen Bai has become part of the manufacturing
contract ensuring timely delivery. Albendazole is pro-
vided by WHO as part of their ongoing program of
deworming in Viet Nam. In 2006, it was estimated that
the approximate price for weekly iron-folic acid tablets
and four monthly deworming was USD0.20 per women
per year based on UNICEF bulk supplied iron-folic acid
tablets (personal communication D. Satori, unpublished
results). Adjusted for locally produced, blister packed tab-
lets, this cost is now approximately USD0.30 per woman
per year (2009 pricing).
A major challenge is to maintain the current high level of
participation and enthusiasm as the project is integrated
into the routine provincial health program. This is most
likely to be achieved if WRA perceive a health benefit from
taking weekly iron and regular deworming. To assist this,
survey results have been communicated to commune and
village health workers to pass on to their communities.
Table 2: Main factors for consideration in future preventive programs to reduce the burden of anemia and hookworm in women
Activity Output
Identify appropriate local partners The Yen Bai CMPE was able to advise the national and international 
partners on local issues and facilitate communication between the 
important provincial authorities and all levels of the provincial health 
service structure.
Conduct informative situation analysis Formative research and a valid needs assessment for the project was 
conducted which identified that anemia and hookworm disease were 
major health problems for the community as well as health authorities. 
This was vital to providing the program with clear purpose, helped with 
the development of goals and gave the program credibility
Develop plan collaboratively Open discussions between all parties ensured the program design would 
be accepted and supported by all involved.
Maintain communication Regular meetings between the project team and local parties ensured 
that results were communicated to the province in a timely manner and 
potential problems could be resolved before they influenced outcomes.
Appropriate point of contact for target group Village health workers were identified as the most appropriate point of 
contact because they lived in the communities and were well respected 
among the target group. VHW would also feel ownership and 
responsibility for the program and thereby help with sustainability
Appropriate, adaptable training materials developed and assessed Culturally appropriate training and IEC materials ensured VHW had 
sufficient knowledge of the health problems being addressed and the 
resources to communicate that knowledge to WRA.
Packaging of tablets With a small increase in cost a more acceptable form of packaging was 
developed.
Independent monitoring of the intervention conducted early in the 
process
The survey conducted early (at three months) in the intervention 
resulted in modification of the training, materials and repackaging of the 
tablets.
Intervention supplied free of charge This helped with equitable distribution and helped successful 
implementation of the intervention
Incentives for staff Small payments and feedback to staff about the project results were 
given to staff during the course of the program. These helped the 
implementation of the program
Impact evaluation Evaluation surveys to document impact have provided project partners 
with data and information for advocacy with stakeholders and policy 
makers, and dissemination of results to the international community.Page 8 of 10
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health authorities to maintain the program long term.
During the demonstration project, VHWs, commune and
district staff in the two districts received a small monthly
payment from project funds. This was discontinued when
the program expanded to the entire province, and provin-
cial authorities have since made their own arrangements
for a small sustainable payment at the time of biannual
deworming.
Conclusion
In conclusion, the strong commitment of all partners to
the intervention has led to excellent participation levels
and a significant clinical impact. The program has been
expanded province-wide reaching an estimated 250,000
WRA. As well as improving the overall health of women,
this will facilitate women entering pregnancy with ade-
quate iron stores, thereby improving pregnancy out-
comes, with enhanced potential for healthy growth and
development of infants in the crucial early years.
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